StonvexLoading…
StonvexStonvexStonvexCore line items from GOCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.91M | $361.85M | $349.21M | $315.02M |
Operating Income | $-34.79M | $-412.90M | $-380.63M | $-92.72M |
Net Income | $-37.17M | $-257.13M | $-224.53M | $-58.69M |
EPS (Diluted) | $-2.36 | $-20.17 | $-19.14 | $-5.72 |
Total Assets | $917.92M | $987.38M | $1.03B | $1.31B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $39.88M | $32.90M | $32.08M | $35.59M |
Free Cash Flow OCF − CapEx | $6.99M | $-130.19M | $-91.12M | $-56.10M |
Shares Outstanding | 16.20M | 12.94M | 11.88M | 10.60M |